Recent advances in management of type 2 diabetes and nephropathy: Lessons from the RENAAL study

This publication has 16 references indexed in Scilit:

• Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
  New England Journal of Medicine, 2001
• The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)
  Journal of the Renin-Angiotensin-Aldosterone System, 2000
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy
  The Lancet, 2000
• Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
  Kidney International, 1999
• Long-term effects of ramipril and nitrendipine on albuminuria in hypertensive patients with type II diabetes and impaired renal function
  Journal of Human Hypertension, 1999
• Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy
  Diabetes, 1997
• Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy
  Kidney International, 1996
• Determinants of end-stage renal disease in Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus and proteinuria
  Diabetologia, 1993
• Leukocyte Count and Risk of Major Coronary Heart Disease Events
  American Journal of Epidemiology, 1992
• The changing natural history of nephropathy in type I Diabetes
  The American Journal of Medicine, 1985